Twenty five children in remission, who were asymptomatic and who had last been treated at least two years before for acute lymphoblastic leukaemia, were examined neurologically and neuropsychologically. Their treatment included early cranial irradiation (24 Gy or 18 Gy), intrathecal methotrexate, and systemic chemotherapy. One half of the children demonstrated a decline in head circumference centile, which occurred in all patients treated with 24 Gy and in those patients treated with 18 Gy under the age of 3 years. In those children whose head growth was reduced, performance was significantly impaired in neuropsychological tests designed to assess concentration and short term memory. These children also developed clinically important learning difficulties in the classroom. Minor neurological dysfunction was present in almost half of the entire group. These data suggest that the treatment employed to prevent central nervous system leukaemia (primarily cranial irradiation) has a deleterious effect on head and brain growth and intellectual function.
The current use of combination chemotherapy and central nervous system directed treatment has resulted in prolonged disease free survival in most children with acute lymphoblastic leukaemia. 1 This survival may be associated with neuropsychological complications, however, which have been attributed primarily to the use of cranial irradiation.2A
Previous studies have focused on the neuropsychological state of asymptomatic childhood survivors of acute lymphoblastic leukaemia, because of concern over learning difficulties and consequent school delay.2-5 There is little information on the neurological findings of these children with respect to the prevalence of 'soft' neurological signs and, in particular, patterns of head and, presumably, brain growth.
The purpose of this paper is to present the patterns of head growth and neurological and neuropsychological findings in 25 children, who were disease free and who were studied at least two years after the cessation of treatment for acute lymphoblastic leukaemia. The study has employed a number of psychological tests, some of which have not been used previously in the assessment of children treated for acute lymphoblastic leukaemia, and which can be administered during a routine medical clinical visit.
Patients and methods

PATIENTS
Twenty five children who were in remission, and who had last been treated at least two years before for acute lymphoblastic leukaemia, underwent neurological and neuropsychological evaluation. Countries oforigin included Canada/North America (19 patients) and two patients from each of Sweden, Portugal, and India. The patients' ages at diagnosis ranged from 1-4-8-8 (mean [3] [4] [5] years and at examination, from 7-0-18-5 (mean 11-0) years. The children had been off treatment for between two and 12 (mean four) years at the time of evaluation. All Thirteen of the 25 children had clinically important learning difficulties, of whom 10 were at least one year behind at school; eight of these 10 had a reduction in head growth. A further three children (two showing a decline in head circumference) had a more specific learning difficulty with mathematics which necessitated placement in a remedial class for this subject.
Major neurological complications were seen in only one child ( Regression analysis revealed that neither parental education nor socioeconomic status accounted for any of the cognitive variability (neuropsychological performance or school delay) seen in the children.
Discussion
In this study we have shown that a reduction in the pattern of head growth seems to relate closely to neuropsychological difficulties and school delay among childhood survivors of acute lymphoblastic leukaemia. Almost half of the children in this series had a decrease in head circumference centile. A reduction occurred in all six children who received a radiation dose of 24 Gy, irrespective of age at diagnosis. In contrast, a reduction occurred in less than half of those children who received a dose of 18 Gy and, in those children whose head circumference centiles were unchanged, all were over 3 years of age at diagnosis. The dosages and durations of administration of intrathecal methotrexate were similar in the two groups of children. Thus intrathecal methotrexate did not appear to be a significant factor in the decline in head growth. However, a contributory effect of the drug cannot be excluded. Although the mean period of follow up was slightly shorter in the patients treated with 18 Gy who did not demonstrate a change in head circumference centile (compared with the follow up period in those that did), it is unlikely that this was significant. The mean age at follow up was significantly older in the group of children whose head circumference changed; however, we do not feel that this altered significantly any of the results with respect to either the number of children with reduced head growth, or incidence of school delay, or performance on neuropsychological testing. Head circumference centiles were unchanged in the six children who did not receive cranial irradiation, of whom three were diagnosed and received intrathecal methotrexate before their third birthday. Despite the small number of patients in this study, these observations suggest that in the treatment of acute lymphoblastic leukaemia the greatest risk of affecting head and presumably brain growth is associated with cranial irradiation administered under the age of 3 years. As far as we are aware, this association has been reported only once previously, in abstract form. In the study by Urion et al all the children had received 24 Gy cranial irradiation and combination chemotherapy, of whom half had microcephaly (defined by an occipitofrontal head circumference less than the second centile). 14 Finally, the differing methods and conflicting findings of at least 28 outcome studies of acute lymphoblastic leukaemia have caused considerable confusion over the neuropsychological effects of central nervous system directed treatment. 27 Our findings suggest that among childhood survivors of acute lymphoblastic leukaemia, it may only be those children who show a reduction in head growth who develop neuropsychological complications. Further studies which specifically examine the association between the patterns of head growth and cognitive function in these children may help to resolve some of this confusion.
Although this study is small and retrospective, our findings suggest that central nervous system directed treatment (predominantly cranial irradition) has a significant adverse effect on head (and presumably brain) growth and cognitive development that is in part related to age.
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